Detalles de la búsqueda
1.
Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro.
J Proteome Res
; 11(4): 2452-66, 2012 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-22424448
2.
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.
Mol Cancer
; 10: 129, 2011 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-21999842
3.
Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
J Proteomics
; 119: 218-29, 2015 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25724726
4.
Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines.
J Proteomics
; 96: 300-13, 2014 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24269351
5.
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors.
PLoS One
; 8(1): e53668, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23326482
6.
Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.
PLoS One
; 6(2): e16833, 2011 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-21347291
7.
Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.
PLoS One
; 6(4): e19164, 2011 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21541334
8.
Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activation.
Blood
; 109(5): 2147-55, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17090651
Resultados
1 -
8
de 8
1
Próxima >
>>